NASDAQ:ESRX

92.48
0.00 (0.00%) 1d
0
COMMENT
Merged with Cigna, an insurer. Whole sector is under pressure because of a recent announcement. Important area which helps keep medical expenses low. He's looking at the sector.
wholesale distributors
COMMENT
He watches this peripherally. He watches its acqusition by Cigna. It's a pharmacy beneft; they did have a mail-order pharmacy, an area that may attract political rhetoric. The deal may close at month's end--let's see how that goes.
wholesale distributors
HOLD

He is not sure about the seasonality of this, but technically, it has been in a longer-term downward trend, and just recently broke the downward trend. It's now trending higher and is outperforming the market. It’s broken above 2 resistance points. He would stick with this for a trade coming into springtime.

wholesale distributors
COMMENT

There are rumours that Amazon (AMZN-Q) is going into the drug area. For the American people, that would be a wonderful thing, because it would provide transparency and price for drugs, which they don’t have. Chart shows this has been in a downward channel since the middle of 2016. Fundamentally, it is not looking strong. If he owned, he would set a Stop on it, looking to get out.

wholesale distributors
DON'T BUY

He stayed away from the pharmacy benefits management space. Drug prices are extremely elevated in the US compared to Europe. Selling prices can fall a lot. Most popular drugs are 20-30% cheaper in Europe than in the US.

wholesale distributors
PAST TOP PICK

(A Top Pick Nov 23/15. Down 21.3%.) The fundamentals are fine. They are having record earnings this year and are guiding for record earnings next year. Unfortunately, they announced that one of their biggest customers, Anthem, is shopping around its contract, which is going to hurt earnings. Also, they got a couple of subpoenas. The sentiment for healthcare is horrible.

wholesale distributors
COMMENT

(Market Call Minute.) Favourite pharmaceutical company? This is not really a pharmaceutical company, but an intermediary between the pharmaceutical companies and the end users. He feels that is a safer place to be.

wholesale distributors
COMMENT

This space has been tough right now. They are having a little bit of client attrition, with contracts rolling over to other providers. Also, this is a sector that has headwinds. There is a fair bit of uncertainty in the story.

wholesale distributors
BUY

He is buying a lot of this. The only independent pharmaceutical benefits company left standing. The main reason it is down is that one of its customers, Anthem (ANTM-N), (30% of its revenues), is suing because they want a better deal and some upfront payment. People are worried that in 2019, when their deal comes to an end, that Anthem won’t re-sign with them. Shares were almost $90 a few months ago, and are now at $67, so he thinks the problem is already priced into the stock. Meanwhile this is a big generator of free cash flow, and using all its free cash flow to buy back stock. Retiring its shares at a dramatic level.

wholesale distributors
PAST TOP PICK

(A Top Pick March 24/15. Down 15.31%.) He still likes this. Prescription Management Services is a great industry. At the start of the year, the entire sector just fell off a cliff. People had decided that healthcare stocks were so 2015, and didn’t want to own them anymore. He thinks that was overdone. He is still Buying.

wholesale distributors
TOP PICK

This is a toll road. They have 90 million lives that they cover in the US. When people join drug plans they are covered under drugs, and this company, which has huge buying power keeps the drug prices low. A great retention rate of 98%. The only standalone and at some point he can see it getting acquired or merge with Walgreens. Generating a lot of free cash. Has been buying back a significant amount of shares over time.

wholesale distributors
COMMENT

A pharmacy benefits manager (PBM) which basically creates a large buying pool on behalf of their holders. Thinks this whole group is interesting, but he has chosen to play it by owning CVS Health (CVS-N), which owns a company called CareMark, a competitor of this company. He would prefer CVS Health instead.

wholesale distributors
COMMENT

The only pure play pharmaceutical manager that is publicly traded. This is an industry that is an oligopoly and has pricing power.

wholesale distributors
TOP PICK

It’s like a buyer’s group. They are a toll road for drugs, getting profit off a spread between the usual price and a lower one they negotiate based on the bulk they are dealing with. The payout ratio is small so it can go up a lot. You don’t care who has the best drug.

wholesale distributors
COMMENT

When you see a severe reaction to earnings, you have to dig down to see what caused this. Sometimes it is something not long lasting. The whole pharmacy benefits space is a good long-term play. He owns and would prefer CVS Caremark (CVS-N), which is a direct competitor. This gives you a pharmacy benefit play but it also gives you a drugstore play, which gives you a natural hedge.

wholesale distributors
Showing 1 to 15 of 20 entries

Express Scripts Inc(ESRX-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Express Scripts Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Express Scripts Inc(ESRX-Q) Frequently Asked Questions

What is Express Scripts Inc stock symbol?

Express Scripts Inc is a American stock, trading under the symbol ESRX-Q on the NASDAQ (ESRX). It is usually referred to as NASDAQ:ESRX or ESRX-Q

Is Express Scripts Inc a buy or a sell?

In the last year, there was no coverage of Express Scripts Inc published on Stockchase.

Is Express Scripts Inc a good investment or a top pick?

Express Scripts Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Express Scripts Inc.

Why is Express Scripts Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Express Scripts Inc worth watching?

In the last year, there was no coverage of Express Scripts Inc published on Stockchase.

What is Express Scripts Inc stock price?

On 2018-12-20, Express Scripts Inc (ESRX-Q) stock closed at a price of $92.48.